|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.120 USD | +4.57% |
|
+4.57% | -63.38% |
| Capitalization | 460M 392M 366M 344M 634M 41.65B 692M 4.27B 1.66B 19.63B 1.73B 1.69B 71.62B | P/E ratio 2025 * |
-2.85x | P/E ratio 2026 * | -5.88x |
|---|---|---|---|---|---|
| Enterprise value | 1.25B 1.07B 999M 940M 1.73B 114B 1.89B 11.66B 4.52B 53.58B 4.71B 4.61B 195B | EV / Sales 2025 * |
0.67x | EV / Sales 2026 * | 0.5x |
| Free-Float |
94.8% | Yield 2025 * |
10.8% | Yield 2026 * | 2.57% |
Last Transcript: Evolent Health, Inc.
| 1 day | +4.57% | ||
| 1 week | +4.57% | ||
| Current month | -1.90% | ||
| 1 month | -0.96% | ||
| 3 months | -54.32% | ||
| 6 months | -50.18% | ||
| Current year | -63.38% |
| 1 week | 3.81 |  | 4.13 |
| 1 month | 3.5 | | 4.55 |
| Current year | 3.5 | | 12.98 |
| 1 year | 3.5 | | 12.98 |
| 3 years | 3.5 | | 36.7 |
| 5 years | 3.5 | | 39.78 |
| 10 years | 3.5 | | 39.78 |
| Manager | Title | Age | Since |
|---|---|---|---|
Seth Blackley
CEO | Chief Executive Officer | 46 | 2020-09-30 |
Dan McCarthy
PSD | President | - | 2022-09-14 |
John Johnson
DFI | Director of Finance/CFO | 41 | 2019-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Seth Blackley
BRD | Director/Board Member | 46 | 2018-04-17 |
Peter Grua
BRD | Director/Board Member | 70 | 2020-01-31 |
Craig Barbarosh
BRD | Director/Board Member | 57 | 2020-12-20 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.57% | +4.57% | -63.80% | -85.37% | 460M | |
| -2.71% | -7.74% | -2.41% | +26.16% | 36.7B | |
| +0.62% | -5.85% | -6.09% | +312.08% | 16.27B | |
| -2.35% | -3.28% | -2.84% | +48.16% | 5.51B | |
| -6.60% | -3.81% | - | - | 2.26B | |
| +1.32% | +8.31% | -4.67% | -12.32% | 1.97B | |
| +2.06% | +4.20% | - | - | 1.31B | |
| -0.41% | -3.41% | -12.23% | -41.77% | 1.05B | |
| -1.08% | +2.00% | +10.36% | +276.03% | 845M | |
| +1.02% | +3.12% | -50.50% | -73.53% | 841M | |
| Average | -0.36% | -0.43% | -16.52% | +56.18% | 6.72B | |
| Weighted average by Cap. | -1.64% | -5.71% | -4.53% | +100.02% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1.88B 1.6B 1.49B 1.41B 2.59B 170B 2.83B 17.44B 6.76B 80.15B 7.04B 6.9B 292B | 2.42B 2.06B 1.92B 1.81B 3.33B 219B 3.64B 22.44B 8.7B 103B 9.06B 8.87B 376B |
| Net income | -166M -141M -132M -124M -229M -15.03B -250M -1.54B -598M -7.08B -623M -609M -25.85B | -78.48M -66.85M -62.45M -58.76M -108M -7.11B -118M -729M -283M -3.35B -294M -288M -12.22B |
| Net Debt | 795M 677M 633M 595M 1.1B 72.02B 1.2B 7.39B 2.86B 33.95B 2.98B 2.92B 124B | 743M 633M 591M 556M 1.02B 67.26B 1.12B 6.9B 2.68B 31.71B 2.79B 2.73B 116B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-12 | 4.120 $ | +4.57% | 2,444,432 |
| 25-12-11 | 3.940 $ | +1.55% | 3,280,113 |
| 25-12-10 | 3.880 $ | -1.52% | 5,438,786 |
| 25-12-09 | 3.940 $ | +0.25% | 2,246,562 |
| 25-12-08 | 3.930 $ | -0.25% | 3,600,994 |
Delayed Quote Nyse, December 12, 2025 at 04:00 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- EVH Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition